INTRODUCTION
of insulin-like growth factor binding protein-5, neurofilament subunit L, adenosine A2A receptor, plasminogen activator inhibitor-1, intercellular adhesion molecule-1, p16, and p27 is altered in senescent endothelial cells. [3] [4] [5] [6] The vascular endothelial cells between blood and tissues maintain homeostasis through their interaction with plasma. They have the capacity to generate new blood vessels and to maintain their integrity, and their normal function is important for inflammatory reactions, coagulation, wound healing, and tissue growth. 7, 8 The senescence of vascular endothelial cells is associated with atherosclerosis, hypertension, congestive heart failure, sepsis, diabetes, thrombotic thrombocytopenic purpura, systemic sclerosis, systemic lupus erythematosus, and the metastasis of cancer, as well as the intrinsic aging of the skin. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] However, the precise mechanisms of senescence have not been elucidated. The growth, aging, and apoptosis of vascular endothelial cells can be induced or suppressed in response to stimulation by serum factors or adjacent cells. Since most pathophysiological conditions occur at the level of the microvasculature, endothelial cells are very suitable as a research model for the aging of skin, prompting us to use these cells. Previously, our studies have shown that kinetin, epigallocatechin-3-gallate, all-trans retinoic acid, and selenium have anti-aging effects on cultured human dermal microvascular endothelial cells (HDMECs). 19, 20 Using these materials, several proteins suspected of being aging-related proteins were detected in proteomic maps of HDMECs obtained before and after exposure to anti-oxidants. 20 Moesin, Rho guanosine-5'-diphosphate-dissociation inhibitor, and actin played significant roles, especially moesin.
Moesin is an ezrin/radixin/moesin (ERM) protein and belongs to the band 4.1 superfamily. Members of the band 4.1 superfamily share a 300-amino-acid domain called the 4.1 ezrin, radixin, and moesin (FERM) domain. [21] [22] [23] Moesin acts as a cytoskeleton protein connecting cell membrane proteins and actins located underneath the cell membrane. It maintains cell polarity or integrity and regulates the functions of cell membrane proteins. It also has a signal transduction function in addition to its role in remodeling the cytoskeleton. [24] [25] [26] Recently, it was reported to be associated with conjugation between T cells and antigen-presenting cells, leukocyte diapedesis, and endothelial cell migration and permeability. [27] [28] [29] It has been suggested as a potential prognostic marker of thyroid cancer, renal cell carcinoma, and pancreatic adenocarcinoma. [30] [31] [32] Ezrin induces apoptosis via Fas, 33 and Gα13 activation rescues moesin-depletion-induced apoptosis in F9 teratocarcinoma cells. 34 These findings suggest that ERM proteins are closely related to apoptosis and aging.
To examine the functional role of moesin in skin aging, we examined the effect of moesin on aging and metabolic function using a short hairpin-RNA (shRNA) lentivirus to suppress moesin expression in subcultured HDMECs. In addition, the difference in moesin and p16 expression in young and old skin tissues was examined.
HDMEC culture
Human dermal microvascular endothelial cells were purchased from Cambrex (Walkersville, MA, USA). HDMECs were prepared and treated in a tissue incubator with 0.1% gelatin, using microvascular endothelial cell medium-2 (Cambrex) containing human epidermal growth factor, hydrocortisone acetate, vascular endothelial growth factor, human fibroblast growth factor-B, gentamicin, amphotericin B, 5% fetal bovine serum, R3-insulin growth factor-1, and ascorbic acid. They were subcultured serially from passage 5 to 25 at 37˚C in a CO2 incubator.
Suppressing moesin expression with a shRNA-lentiviral vector
Preparation of shRNA-lentiviral vector targeting moesin A shRNA-lentiviral vector targeting moesin was prepared by inserting a synthetic double-stranded oligonucleotide (5'-GCAGCGCATTGACGAATTTGA-3') in the EcoRIXbaI restriction enzyme site of shLenti2.4R lentiviral vector (VectorCore A, Daejeon, Korea). The shLenti2.4R lentiviral vector was designed to express shRNA at the human U6 promoter and to express red fluorescent protein (RFP) from the hCMV promoter. A shLenti2.4R lentiviral vector with a scrambled shRNA (5'-AATCGCATTAGCGTAT GCCGTT-3') insert was used as the control vector. The scrambled shRNA lacks homology with any mammalian mRNA sequence.
shRNA-lentiviral vector production The recombinant lentiviral vector was manufactured by VectorCore A. 293T cells were transfected with transfer vector, VSV-G expression vector, and gag-pol expression vector in a 1 : 1 : 1 ratio using LipofectAMINE PLUS (Invitrogen, Carlsbad, CA, USA). The supernatant of the culture medium containing the lentiviral vector was collected 48 h after transfection and was refined using 0.45-µm membrane filters (Nalgene, Rochester, NY, USA).
Transfection of shRNA-lentiviral vector to HDMECs The HDMECs were mixed with 1 mL of shRNA-lentiviral vector without culture medium on a plate. After adding 8 µg of Polybrene (hexadimethrine bromide, Sigma, St. Louis, MO, USA), the plate was shaken and cultured at 37˚C in 5% CO2 for 6-8 h.
MATERIALS AND METHODS
Confirmation of HDMEC transfection with the expression of RFP To confirm whether the HDMECs were transfected with shRNA-lentiviral vector, red fluorescent protein (RFP) expression was examined in HDMECs at passages 6, 10, and 20 using fluorescence microscopy.
Phase-contrast microscopic examination
Phase-contrast microscopy (Olympus, Tokyo, Japan) was used to confirm the senescence of HDMECs and to examine the morphologic changes of transfected HDMECs according to the number of serial passages.
Senescence-associated-β β-galactosidase staining The modified senescence-associated-β-galactosidase (SA-β-gal) assay was used to compare senescence according to the number of serial passages of untreated HDMECs, control vector-treated HDMECs, and moesin-knock-down HDMECs. The cells were washed twice with phosphatebuffered saline (PBS), fixed in 3% (v/v) formaldehyde for 3 min at room temperature, washed again in PBS, and incubated for 12 h with 500 µL of β-GAL solution containing 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal), 5 mM potassium ferrocyanide, 150 nM NaCl, and 2 mM MgCl2. The cells were viewed and photographed with a light microscope fitted with a digital camera.
Measuring the doubling time and doubling level of the cumulative cell population
To obtain lifespan curves, cell cultures were serially passaged until the end of their proliferative capacity in vitro and the population-doubling levels were determined. The time required for 1×10 5 HDMECs to double was regarded as the doubling time.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Extracting total RNA Virus-untreated HDMECs, HDMECs over passage 25, control vector-treated HDMECs, and moesin-knock-down HDMECs were serially cultured. Total RNA was isolated using an RNeasy Mini Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer's instructions. The RNA concentration was measured at 260 nm using an UV-1601 PC spectrophotometer (Shimadzu, Kyoto, Japan).
First strand cDNA synthesis cDNA was synthesized from 1 µg of extracted total RNA using AccuPower RT PreMix (Bioneer, Seoul, Korea) and a PCR system 2700 (Applied Biosystems, Singapore, Singapore).
PCR of moesin and p16
Polymer chain reaction amplification was carried out using 1 µg of cDNA as the template in 20 µL of PCR mixture containing 1 µL of 20 pmole primer with AccuPower RT PreMix (Bioneer). The PCR fragments were visualized on 2% agarose gels containing 5 µg/mL ethidium bromide. The same amount of actin was used as a standard for quantification. The moesin primers were 5'-CCACCATGCC-CAAAACGATC-3' (forward) and 5'-GGTGCCCATTA-CATAGACTC-3' (reverse). The p16 primers were 5'-AGCATGGAGCCTTCGGCTGAC-3' (forward) and 5'-CTGTAGGACCTTCGGTGACTGAT-3' (reverse).
Western blot analysis
Immunoblotting was used to examine the moesin and p16 expression. Cells were transferred to a microcentrifuge tube and centrifuged for 10 min at 10,000 × g and 4˚C. The supernatant was collected, and all of the supernatant was used as the cell lysate. After sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), the proteins were transferred to an nitrocellulose (NC) membrane in a container filled with transfer buffer solution for 2 h at 400 mA and 10-15 V. The membrane was blocked with 5% blotting grade non-fat dry milk (Bio-Rad Laboratories, Hercules, CA, USA) for 60 min. Primary antibodies to moesin, p16, and actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were diluted to 200 µg/mL in blocking solution and added to the membranes, and the mixture was incubated for 60 min. Antibody to horseradish peroxidase (HRP; Santa Cruz Biotechnology) diluted to 1 : 2,000 in blocking buffer solution was added as the secondary antibody, and reacted with the primary antibody for 60 min. The membrane was washed three times with TBST buffer solution for 5 min, and stained with 3,3,5,5-tetramethylbenzidine.
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay
The tetrazolium salt MTT was used to compare the cellular metabolic capacities. Each well of a 96-well plate was seeded with 1×10 5 HDMECs and preincubated at 37˚C in a CO2 incubator. The culture medium was removed and the cells were incubated for 3 h with 200 µL of 0.5 mg/mL MTT (Boehringer, Mannheim, Germany). Metabolically active cells reduce the dye to purple formazan. The formazan crystals dissolved with 200 µL of dimethyl sulfoxide (DMSO; Sigma), and the absorbance was measured on an ELISA reader (Bio-Rad Laboratories), using a reference wavelength of 630 nm and a test wavelength of 570 nm.
Tissue biopsy
To examine the expression of moesin and p16 in skin Ju Hee Lee, et al. tissues, biopsies of the prepuce of neonates and the normal abdominal skin of a 10-year-old child and an 86-year-old adult were obtained. The neonatal prepuce was obtained from circumcision, and the abdominal skin was obtained with a 3-mm punch. The specimens were stored in TissueTek (Sakura Finetechnical, Tokyo, Japan) at -70˚C.
Immunohistochemical staining
The stored tissues were cryosectioned at 6 µm and attached to silane-coated slides (Muto Pure Chemicals, Tokyo, Japan). They were fixed in acetone for 15 min and washed with PBS. Immunohistochemical staining was performed using the Histostatin-DS kit (Zymed Laboratories, San Francisco, CA, USA). To suppress nonspecific binding, the samples were placed in a blocking solution for 10 min. Mouse anti-human moesin monoclonal antibodies (GeneTex, San Antonio, TX, USA) diluted 1 : 25 with PBS containing 5% bovine serum and anti-human CD31 monoclonal antibodies (BD Biosciences, San Jose, CA, USA) were used and incubated at 4˚C. The biotinylated secondary antibody was incubated for 10 min at room temperature. Streptavidin alkaline phosphatase (AP) conjugate was incubated for 10 min and nitroblue tetrazolium solution (NBT) was used as a substrate for the chromogen. For double immunohistochemical stains, double staining enhancer solution was added and treated for 30 min at room temperature. This procedure was then repeated with streptavidin horseradish peroxidase (HRP) instead of AP conjugate and 3-amino-9-ethylcarbazole (AEC) solution was used as the substrate for the chromogen.
Confirming the infection of HDMECs by shRNAlentivirus At passage 6, HDMECs were transfected with shRNAlentivirus, which knocked-down moesin expression, and RFP expression was examined to confirm whether the HDMECs had been transfected by the viral vector. Control vector-treated HDMECs and shRNA-lentivirus-treated HDMECs continuously showed RFP expression through passages 10 and 20 ( Fig. 1) .
Correlation between moesin expression and the senescence of moesin knock-down HDMECs
Contrast microscopic findings Using contrast microscopy, moesin knock-down HDMECs were compared with virus-untreated HDMECs, HDMECs at passages higher than passage 25, and control vector- (Fig. 2) .
Growth retardation of moesin knock-down HDMECs
The growth of HDMECs was observed through lifespan curves over time in the cultures. Within the culture period, all HDMEC cultures showed an initial proliferation phase and late growth retardation phase. In comparison with control vector-treated HDMECs, the doubling time of moesin knock-down HDMECs was delayed by 3 h at passage 6 and 10 h at passage 22 (Fig. 3A) . The doubling level of the cumulative cell population in moesin-knockdown HDMECs was much less than that in virus-untreated HDMECs (Fig. 3B ).
The expression of moesin and p16 protein and RNA in moesin knock-down HDMECs
The expression of moesin and p16 in cells was observed using RT-PCR and Western blotting. Moesin knock-down HDMECs expressed less moesin RNA than control vectortreated HDMECs (Fig. 4A ). In addition, the RNA expression of p16 in HDMECs at late passages and moesin knockdown HDMECs was higher than that in control vectortreated HDMECs (Fig. 4B) . In applying Western blotting, reduced expression of 
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moesin and higher expression of p16 were observed in moesin knock-down HDMECs, compared to control vectortreated HDMECs (Fig. 4C) .
Reduction of cellular metabolic activity
The MTT assay was performed in HDMECs at passage 20 to compare cell metabolic activity. Compared with control vector-treated HDMECs, cellular metabolic activity decreased in HDMECs at passage 39 and moesin-knock-down HDMECs (p = 0.012 and 0.016, respectively) (Fig. 5 ).
Immunohistochemical staining of moesin, p16, and CD31 of skin tissues
The neonatal prepuce and the skin of the 10-year-old child stained well with moesin, whereas the skin of the 86-yearold adult did not stain. Conversely, cells stained with p16 were not detected in the neonatal prepuce or the skin of the 10-year-old child, while the skin of the 86-year-old contained many cells stained with p16 (Fig. 6A) . To exclude the influence of the distribution of blood vessels between the abdominal skin of the child and elderly adult on staining with moesin and p16, double staining with moesin/CD31 and with p16/CD31 was performed. The abdominal skin of the 10-year-old child and 86-year-old adult showed comparable CD31-positive cells and tissues (Fig. 6B ).
With aging, the function of organs decreases gradually with cellular senescence. The replicative senescence of cells resulting in the loss of replication capacity and a change in the function and morphology of cells may be a key to research on the pathophysiology of aging. 35 Ezrin, radixin, and moesin constitute the ERM protein family. ERM proteins are highly conserved throughout evolution. More than 75% identity is observed in the FERM domain and F-actin binding site of vertebrates (ezrin, 
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radixin, and moesin), Drosophila (Dmoesin), and C. elegans (ERM-1).21,22 ERM proteins are essential for the morphogenesis of the apical domain of different epithelial cell types and regulate the functions of membrane proteins. 23, 24, 32 Ezrin is part of a complex that regulates the Na + /H + exchanger NHE3 in intestinal and renal brush border microvilli 36 and influences transport through cellular membrane proteins. 37 Dmoesin in Drosophila has a role in the physiological functions of photoreceptors by interacting with transient receptor potential (TRP) protein. 38 Phagosome maturation in macrophages and dendritic cells depends on the activation of Rho via Rho kinase on ERM proteins, 39 and ERM proteins are important downstream and upstream effectors of Rho GTPase, which is involved in phagosome maturation and phagocyte movement toward a dying cell. 27, 40 Few studies have examined the role of moesin in cellular senescence, although the functional role of moesin in cellular aging has been suggested from a number of reports, which have found that ERM protein induces Fasmediated apoptosis, 33 and that the apoptosis of cancer cells was induced by the decrease in moesin expression. 34 Therefore, we characterized the function of moesin by knocking out the moesin gene using shRNA.
RNA interference (RNAi) has become a widely used technique for silencing gene expression. Successful application of RNAi in mammalian cells depends on knockingdown targeted transcripts and the effective intracellular delivery of either preformed short interfering RNAs (siRNAs)/ shRNAs or vector expressing si/shRNAs. Chemically synthesized siRNAs are incorporated into the RNA-induced silencing complex and the delivery results in sequencespecific silencing of the expression of the corresponding gene. 41 RNAi can also be induced by the endogenous expression of shRNAs, which are structurally related to a highly conserved class of small RNAs known as microRNAs (miRNAs) that mediate RNAi through a translational inhibition mechanism. 42 We used shRNAs for RNAi because knock-down by siRNAs was not maintained during the next passage. In contrast, we confirmed that knockdown by shRNA-lentiviral vector was maintained until passage 22 using RFP expression.
Contrast microscopy and the SA-β-gal assay were used to assess the senescence of vascular endothelial cells. SA-β-gal staining is widely used as a marker of senescence and its usefulness has been reported in human vascular endothelial cells, keratinocytes, fibroblasts, and smooth muscle cells. 43, 44 Nonetheless, we did not perform the SA-β-gal assay in tissue specimens because it has been reported that SA-β-gal stains have low usefulness in vivo. 45 The early appearance of senescent cells was observed in moesin knockdown HDMECs using contrast microscopy and SA-β-gal staining. These cells were clearly different from the virusuntreated HDMECs. The HDMECs treated with scrambled shRNA-lentivirus also showed some changes of senescence. These might have been induced by the virus itself or the reagents used during viral transfection.
The doubling time of moesin knock-down HDMECs was prolonged and growth retardation was detected in the early phase in the life span curve. In addition, cellular metabolic activity decreased in moesin knock-down HDMECs. These findings show that moesin knock-down makes HDMECs senescence not only morphologically but also functionally, and that moesin is a potential biomarker of cellular aging of the skin.
Until now, the suggested aging mechanisms of normal cells have included cellular proliferation, oxidative stress, DNA damage, shortening of the telomere related to tumor suppressor cascades, p16 INK4A , and the ARF-p53 pathway. 46, 47 It has been reported that cellular senescence progresses via p16 activation in response to oxidative stress or telomere shortening rather than the ARF pathway. 1, 48 We showed that p16 expression increased with cell aging, but further studies need to examine whether telomere shorten- 
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ing is associated with p16 and whether moesin is associated with p19 ARF and the p53 pathway via direct DNA. It has also been reported that oxidative stress activates p16 via the stress-activated protein kinase family, p38-MAPK; 49 therefore, a study of p38-MAPK is needed to determine whether moesin is related to the oxidative stress associated pathway. The mitochondria play a major role in the production of reactive oxygen species, and the accumulation of mutated mitochondrial DNA has also been proposed as a cause of cellular aging. 2, 50 We also need to study the association between moesin and mitochondria in the cell cycle and senescence.
Cell senescence or apoptosis is closely related to the cell cycle: if cellular senescence occurs, G1 arrest occurs, and the G1-specific cyclin D1 or cyclin E1, pRB, p16, p21, and p27 undergo change.
6 p16 maintains Rb in its hypophosphorylated form and hypophosphorylated Rb suppresses E2F activation and CDK4/6. Consequently, p16 induces cell cycle arrest. 51, 52 Based on the increased p16 expression in cell senescence, we postulate that the cellular aging caused by moesin knock-down is associated with p16, because p53 and p21 are involved in aging through mechanisms involving DNA damage. Since p16
INK4A expression is directly correlated with the chronological aging of human skin in vivo, and is a biomarker for human aging in vivo, 53 immunohistochemical staining of p16 could be used in studies of skin aging.
To determine the function of moesin, experimental methods could involve the suppression or overexpression of moesin. However, since the overexpression of moesin is anticipated to be associated with oncogenesis in addition to anti-aging, the effect of moesin suppression on the aging of cells was investigated first. We postulate that the selective suppression of moesin in cancer cells may have an anti-cancer effect; indeed, moesin expression is enhanced in cancer cells and it has been suggested as a potential prognostic and diagnostic marker of renal cell carcinoma. 30, 54, 55 In addition, moesin-knock-down with shRNA has been reported to induce the apoptosis of teratocarcinoma cells. 34 Therefore, the possibility of tumor development via moesin overexpression should be examined in future experiments.
Our study showed that the signs of cellular senescence appeared early with moesin knock-down, and that cell cycle arrest occurred on inducing the increased expression of p16. Moesin was postulated to influence cell senescence, and it should be a useful marker for cell senescence, as well as for evaluating the level of aging. If the acceleration of aging were proven in a moesin knock-down animal model, it could be a breakthrough model for aging experiments, and could be used to validate the efficacy of anti-aging treatments. Furthermore, it could be very useful to studies on the pathophysiological mechanism of various diseases of aging, as long as the factors and mechanisms influencing moesin expression can be determined. 
